ArticleFrontiers in immunology2017

CD215+ Myeloid Cells Respond to Interleukin 15 Stimulation and Promote Tumor Progression.

Shouheng Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.